| # | Security | Value | Shares | % Port | Change | Δ Shares |
|---|---|---|---|---|---|---|
| 1 | ABIVAX SA AMERICAN DEPOSITARY SHARES ADRS | $721.7M | 6.48M | 20.6% | REDUCED | -630,511 |
| 2 | CG ONCOLOGY INC COMM | $248.4M | 3.67M | 7.1% | —HELD | 0 |
| 3 | TANGO THERAPEUTICS INC COMM | $220.3M | 10.53M | 6.3% | REDUCED | -2,231,023 |
| 4 | COGENT BIOSCIENCES INC COMM | $190.4M | 4.95M | 5.4% | REDUCED | -921,268 |
| 5 | CENTESSA PHARMACEUTICALS PLC ADRS | $170.3M | 4.29M | 4.9% | —HELD | 0 |
| 6 | DIANTHUS THERAPEUTICS INC COMM | $140.7M | 1.68M | 4.0% | —HELD | 0 |
| 7 | TYRA BIOSCIENCES INC COMM | $124.4M | 3.25M | 3.6% | ADDED | +350.9K |
| 8 | IMMUNOVANT INC COMM | $110.7M | 4.46M | 3.2% | ADDED | +2.80M |
| 9 | BIOCRYST PHARMACEUTICALS INC COMM | $104.9M | 11.02M | 3.0% | NEW | — |
| 10 | MIRUM PHARMACEUTICALS INC COMM | $98.1M | 1.06M | 2.8% | ADDED | +1.00M |
| 11 | VOR BIOPHARMA INC COMM | $96.5M | 5.67M | 2.8% | NEW | — |
| 12 | SPYRE THERAPEUTICS INC COMM | $95.9M | 1.90M | 2.7% | —HELD | 0 |
| 13 | AMYLYX PHARMACEUTICALS INC COMM | $86.8M | 6.24M | 2.5% | —HELD | 0 |
| 14 | DISC MEDICINE INC COMM | $85.8M | 1.34M | 2.5% | NEW | — |
| 15 | DYNE THERAPEUTICS INC COMM | $83.7M | 4.62M | 2.4% | —HELD | 0 |
| 16 | MONTE ROSA THERAPEUTICS INC COMM | $76.0M | 4.62M | 2.2% | —HELD | 0 |
| 17 | SAVARA INC COMM | $67.5M | 12.36M | 1.9% | —HELD | 0 |
| 18 | REVOLUTION MEDICINES INC COMM | $56.1M | 576.5K | 1.6% | ADDED | +140.0K |
| 19 | KODIAK SCIENCES INC COMM | $55.1M | 1.45M | 1.6% | —HELD | 0 |
| 20 | LB PHARMACEUTICALS INC COMM | $45.3M | 1.84M | 1.3% | ADDED | +94.5K |
| 21 | SURROZEN INC COMM | $42.9M | 1.47M | 1.2% | NEW | — |
| 22 | ADC THERAPEUTICS SA COMM | $42.7M | 11.39M | 1.2% | —HELD | 0 |
| 23 | RELAY THERAPEUTICS INC COMM | $42.5M | 4.27M | 1.2% | ADDED | +1.05M |
| 24 | FULCRUM THERAPEUTICS INC COMM | $40.3M | 5.25M | 1.2% | —HELD | 0 |
| 25 | BIOHAVEN LTD COMM | $39.2M | 4.63M | 1.1% | —HELD | 0 |
Holdings data sourced from SEC EDGAR 13F-HR filings. Updated quarterly, approximately 45 days after quarter end. All data is public domain.
Last filed: May 15, 2026